Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases.

Literature DB >> 664136

Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases.

L Andersson, O Eriksson, P O Hedlund, H Kjellman, B Lindqvist.

Abstract

Tranexamic acid is a potent antifibrinolytic drug frequently used in the treatment of haematuria and a number of other haemorrhagic conditions. Since it is eliminated mainly in the urine, the drug accumulates in patients with uraemia. The excretion of tranexamic acid in patients with renal failure has been investigated and dosage recommendations are given for tranexamic acid therapy in cases of renal failure.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1978 PMID： 664136 DOI： 10.1007/BF00255578

Source DB: PubMed Journal: Urol Res ISSN： 0300-5623

11 in total

1. Traumatic hyphaema treated with the antifibrinolytic drug tranexamic acid.

Authors: T Bramsen
Journal: Acta Ophthalmol (Copenh) Date: 1976-04

2. Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers.

Authors: O Eriksson; H Kjellman; A Pilbrant; M Schannong
Journal: Eur J Clin Pharmacol Date: 1974-08-23 Impact factor: 2.953

3. The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage.

Authors: D Tovi
Journal: Acta Neurol Scand Date: 1973 Impact factor: 3.209

4. Antifibrinolytic therapy with Cyklokapron in connection with prostatectomy. A double blind study.

Authors: P O Hedlund
Journal: Scand J Urol Nephrol Date: 1969

5. Antifibrinolytic treatment with tranexamic acid (AMCA) in pediatric urinary tract surgery.

Authors: J S Rö; O Knutrud; H Stormorken
Journal: J Pediatr Surg Date: 1970-06 Impact factor: 2.545

6. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.

Authors: L Andersson; I M Nilsoon; S Colleen; B Granstrand; B Melander
Journal: Ann N Y Acad Sci Date: 1968-06-28 Impact factor: 5.691

7. Plasminogen activators in the endometrium. II. Clinical aspects. Variation in the concentration of plasminogen activators during the menstrual cycle and its relation to menstrual blood loss.

Authors: G Rybo
Journal: Acta Obstet Gynecol Scand Date: 1966 Impact factor: 3.636

8. Effect of tranexamic acid (AMCA) in menorrhagia with intrauterine contraceptive devices.

Authors: L Weström; L P Bengtsson
Journal: J Reprod Med Date: 1970-10 Impact factor: 0.142

9. The effect of tranexamic acid (AMCA) on postoperative bleeding after conization.

Authors: G Rybo; H Westerberg
Journal: Acta Obstet Gynecol Scand Date: 1972 Impact factor: 3.636

10. AMCA (aminomethyl cyclohexane carboxylic acid, Cyklo-kapron) a potent haemostatic agent in urinary tract bleeding.

Authors: L Andersson; I M Nilsson
Journal: Scand J Urol Nephrol Date: 1969

13 in total

Review 1. Clinical pharmacology of aminocaproic and tranexamic acids.

Authors: I M Nilsson
Journal: J Clin Pathol Suppl (R Coll Pathol) Date: 1980

Review 2. Clinical application of inhibitors of fibrinolysis.

Authors: M Verstraete
Journal: Drugs Date: 1985-03 Impact factor: 9.546

3. End Stage Renal Disease: Not a Contraindication for Minor Oral Surgery-Protocol for the Management of Oral Surgery patients with ESRD on Hemodialysis.

Authors: Sneha Pendem; G Lakshmi Narayana; Poornima Ravi
Journal: J Maxillofac Oral Surg Date: 2016-07-28

4. Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.

Authors: H Fodstad
Journal: J Clin Pathol Suppl (R Coll Pathol) Date: 1980

5. Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.

Authors: H Fodstad; A Pilbrant; M Schannong; S Strömberg
Journal: Acta Neurochir (Wien) Date: 1981 Impact factor: 2.216

Review 6. Tranexamic acid: a review of its use in the management of menorrhagia.

Authors: Keri Wellington; Antona J Wagstaff
Journal: Drugs Date: 2003 Impact factor: 9.546

7. Renal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data.

Authors: Dominik Stämpfli; Stefan Weiler; Carolyn F Weiniger; Andrea M Burden; Michael Heesen
Journal: Eur J Clin Pharmacol Date: 2020-12-19 Impact factor: 2.953